Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.97 |
| ▸ | DHFR | P00374 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL672423 | 0.81 | NPSR1 (0.66) | NPSR1DHFRLMNACYP2D6HTT | |
| SCHEMBL1938185 | 0.74 | DHFR (1.00) | DHFRLMNA | |
| SCHEMBL14577833 | 0.72 | CYP2D6 (0.70) | DHFRCYP2D6HTTL3MBTL1 | |
| SCHEMBL671703 | 0.70 | NPSR1 (0.52) | NPSR1DHFRLMNA | |
| SCHEMBL670722 | 0.67 | DHFR (0.62) | NPSR1DHFRLMNA | |
| SCHEMBL670945 | 0.67 | DHFR (0.53) | NPSR1DHFRLMNA | |
| SCHEMBL671090 | 0.67 | DHFR (0.62) | NPSR1DHFRLMNA | |
| SCHEMBL671863 | 0.67 | DHFR (0.60) | NPSR1DHFRLMNA | |
| Cycloguanil SCHEMBL140230 | 0.66 | DHFR (1.00) | DHFRLMNA | |
| SCHEMBL671177 | 0.66 | DHFR (0.49) | NPSR1DHFRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3131883-B1 | 5-HT2B ANTAGONISTS | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) | 2018-06-13 | — | — | EP | disclosed |
| US-20180111908-A1 | 5-HT2B Antagonists | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2018-04-26 | — | — | US | disclosed |
| US-9845298-B1 | 5-HT2B antagonists | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2017-12-19 | — | — | US | disclosed |
| US-20170349559-A1 | 5-HT2B Antagonists | NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) | 2017-12-07 | — | — | US | disclosed |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | MALLE GERARD | 2009-08-06 | — | — | US | disclosed |
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | L'OREAL S.A. | 2009-06-04 | — | — | US | disclosed |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | disclosed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | disclosed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180111908-A1 | 5-HT2B Antagonists | HTR2B, HTR5A, VIPR2 | NPSR1 27/4885DHFR 2635/4885LMNA 1479/4885 |
| US-20090139537-A1 | HAIR RELAXING COMPOSITION COMPRISING AT LEAST ONE NON-HYDROXIDE IMINE | KRT18, INMT, INHA | NPSR1 1467/4885DHFR 1710/4885LMNA 117/4885 |
| US-20090194124-A1 | Hair Shaping Kit and Process Comprising at Least One Non-Hydroxide Imine | KRT18, KIT, PRDM7 | NPSR1 4490/4885DHFR 2438/4885LMNA 132/4885 |
| US-20170349559-A1 | 5-HT2B Antagonists | HTR2B, HTR5A, VIPR2 | NPSR1 27/4885DHFR 2635/4885LMNA 1479/4885 |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | NPSR1 4271/4885DHFR 2941/4885LMNA 85/4885 |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | BHMT, KRT18, INMT | NPSR1 1897/4885DHFR 642/4885LMNA 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.